BAM
PCRX icon

Barrett Asset Management’s Pacira BioSciences PCRX Stock Holding History

Barrett Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-72
Closed -$4K – 380
2016
Q1 		$4K Buy
+72
New +$4.21K ﹤0.01% 362

Other funds holding PCRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Barrett Asset Management's PCRX Position: Q2 2016 in Review

Barrett Asset Management sold out of Pacira BioSciences (PCRX) in Q2 2016, closing a stake of 72 shares — an estimated $4K sold.

Barrett Asset Management first reported a position in PCRX in Q1 2016 and held it in 1 quarter. The position peaked at $4K in Q1 2016. 183 funds tracked by Wall St. Rank hold PCRX as of Q2 2016.

  • Barrett Asset Management reported no remaining Pacira BioSciences position as of Q2 2016 after selling out during the quarter.
  • Barrett Asset Management sold 72 Pacira BioSciences shares in Q2 2016, an estimated $4K.
  • Barrett Asset Management first reported a position in Pacira BioSciences in Q1 2016 and held it in 1 quarter.
  • Barrett Asset Management's Pacira BioSciences position peaked at $4K in Q1 2016.
  • 183 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2016.

Based on Barrett Asset Management's 13F filing for Q2 2016, filed 18 Jul 2016.